{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:30:46Z","timestamp":1648582246086},"reference-count":12,"publisher":"The Japan Geriatrics Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. geriat","Nippon Ronen Igakkai Zasshi","Nihon Ronen Igakkai Zasshi","Jpn J Geriat"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3143\/geriatrics.51.569","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T04:16:06Z","timestamp":1424924166000},"page":"569-575","source":"Crossref","is-referenced-by-count":0,"title":["Successful treatment with rituximab in a patient with splenic marginal zone B-cell lymphoma accompanied by cold agglutinin disease"],"prefix":"10.3143","volume":"51","author":[{"given":"Masako","family":"Yasuyama","sequence":"first","affiliation":[{"name":"Department of Medicine, Tokyo Women&apos;s Medical University, Medical Center East"},{"name":"Department of Medicine, Toshima Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Kawauchi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tokyo Women&apos;s Medical University, Medical Center East"},{"name":"Nishiogu Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tokyo Women&apos;s Medical University, Medical Center East"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medicine, Toshima Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Fujibayashi","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Tokyo Women&apos;s Medical University, Medical Center East"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1704","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"2) Fabbri F, Gozzetti A, Lazzi S, Lenoci M, D&apos;Amuri A, Leoncini L, et al.: Activity of Rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia. Clinical lymphoma &amp; myeloma 2006; 6: 496-499.","DOI":"10.3816\/CLM.2006.n.033"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Lymphoma study group of Japanese pathologist: The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int 2000; 50: 696-702.","DOI":"10.1046\/j.1440-1827.2000.01108.x"},{"key":"3","doi-asserted-by":"publisher","unstructured":"4) Franco V, Florena AM, Iannitto E: Splenic marginal zone lymphoma. Blood 2003; 101: 2464-2472.","DOI":"10.1182\/blood-2002-07-2216"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Parry-Jones N, Matutes E, Gruszka-Westwood AM, Swansbury GJ, Wotherspoon AC, Catovsky D: Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. Br J Haematola 2003; 120: 759-764.","DOI":"10.1046\/j.1365-2141.2003.04165.x"},{"key":"5","first-page":"856","volume":"90","author":"M Bennett","year":"2005","unstructured":"6) Bennett M, Sharma K, Yegena S, Gavish I, Dave HP, Schechter GP: Rituximab monotherapy for splenic marginal zone lymphoma. Haematologica 2005; 90: 856-858.","journal-title":"Haematologica","ISSN":"http:\/\/id.crossref.org\/issn\/0390-6078","issn-type":"print"},{"key":"6","doi-asserted-by":"publisher","unstructured":"7) Tsimberidou AM, Catovsky D, Schlette E, O&apos;Brien S, Wierda WG, Kantarjian H, et al.: Outcomes in patient with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone. Cancer 2006; 107: 125-135.","DOI":"10.1002\/cncr.21931"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Kalpadakis C, Pangalis GA, Dimopoulou MN, Vassilakopoulos TP, Kyrtsonis M-C, Korkolopoulou P, et al.: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma. Hematol Oncol 2007; 25: 127-131.","DOI":"10.1002\/hon.820"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Iannitto E, Tripodo C: How I diagnose and treat splenic lymphomas. Blood 2011; 117: 2585-2595.","DOI":"10.1182\/blood-2010-09-271437"},{"key":"9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","volume":"3","author":"C Thieblemont","year":"2002","unstructured":"10) Thieblemont C, Felman P, Berger F, Dumontet C, Arnaud P, Hequet O, et al.: Treatment of splenic marginal zone B-cell lymphoma: An analysis of 81 patients. Clinical Lymphoma 2002; 3: 41-47.","journal-title":"Clinical Lymphoma","ISSN":"http:\/\/id.crossref.org\/issn\/1526-9655","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Duong Van Huyen J-P, Molina T, Delmer A, Audouin J, Tourneau AL, Zittoun R, et al.: Splenic marginal zone lymphoma with or without plasmacytic differentiation. Am J Surg Pathol 2000; 24: 1581-1592.","DOI":"10.1097\/00000478-200012000-00001"},{"key":"11","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood-2003-10-3597","volume":"103","author":"S Berentsen","year":"2004","unstructured":"12) Berentsen S, Ulvestad E, Gjertsen BT, Hjorth-Hansen H, et al.: Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients. Blood 2004; 103: 2925-2928.","journal-title":"Blood","ISSN":"http:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Fodor A, Molnar MZ, Krenacs L, Bagdi E, Csomor J, Matolscy A, et al.: Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma. Pathol Oncol Res 2009; 15: 597-603.","DOI":"10.1007\/s12253-009-9159-8"}],"container-title":["Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics"],"original-title":["\u5bd2\u51b7\u51dd\u96c6\u7d20\u75c7\u3092\u5408\u4f75\u3057\uff0c\u30ea\u30c4\u30ad\u30b7\u30de\u30d6\u304c\u594f\u52b9\u3057\u305f\u813e\u81d3\u8fba\u7e01\u5e2f\u30ea\u30f3\u30d1\u816b"],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:18:51Z","timestamp":1498184331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/geriatrics\/51\/6\/51_569\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3143\/geriatrics.51.569","relation":{},"ISSN":["0300-9173"],"issn-type":[{"value":"0300-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}